FDA SAS Drug Formulation Stability Program
...FDA SAS Drug Formulation Stability Program.. Division of Biometrics.. Center for Drug.....Food and Drug Administration.. Date March 23, 1992.. For further information contact Atiar..
http://www.fda.gov/cder/sas/index.htm (score=100)

CDER Archives
...This report presents a descriptive overview of the evaluable, postmarket adverse drug.....Prescription Drug User Fee Act Report Fiscal Year 1995. SAS Drug Formulation Stability.....Statistics on CDER's 1993-1997 perfomance for drug reviews and post-marketing risk..
http://www.fda.gov/cder/audiences/archives/ (score=32)

Guidance for Industry
...A complicating,but necessary design feature of MDIs is that they contain more formulation.....This guidance is intended to assist manufacturers who are developing or plan to develop.....guidance is not specifically intended for manufacturers of already marketed MDI drug..
http://www.fda.gov/cder/guidance/5308FNL.pdf (score=23)

Therapeutic Equivalence of Generic Drugs Letter
...For example, brand-name and generic drug product manufacturers may want to change the drug.....FDA works with both brand-name and generic drug product manufacturers after a drug product is in the marketplace to assure.....Special precautions are not needed when a formulation and/or a manufacturing change occurs..
http://www.fda.gov/cder/news/nightgenlett.htm (score=23)

...Drug Formulation and Development, and Tissue Engineering Issues Robert S. Langer, Sc.D.....Director, Office of Medical Policy, Center for Drug Evaluation & Research, FDA 3:40 p.m.....Drug Evaluation & Research, FDA 9:00 a.m. Obesity - Research David W.K. Acheson, M.D..
http://www.fda.gov/ohrms/dockets/ac/04/agenda/4039a1_updated%20agenda.doc (score=23)

þÿ
...the drug or component of drug was found unsafe or not effective: aminopyrine, astemizole, cisapride.....Is a sophisticated formulation of the drug.. product required to ensure dosing accuracy.....the sophisticated formulation, is product-to-product uniformity of the drug.. product..
http://www.fda.gov/ohrms/dockets/ac/00/minutes/3634m1.pdf (score=23)

FOOD AND DRUG ADMINISTRATION
...So, if a drug is better than placebo, and with all available tests that drug is safe, that drug is safe and.....Meyer indicated in his slide, there's a package of information with the formulation/device.....Drug A is a solution example, and drug C is perhaps the best-case scenario for a dose response that we have, and I'll show..
http://www.fda.gov/ohrms/dockets/ac/01/transcripts/3763t1.htm (score=13)

þÿ
...If a drug sensitivity, chemical irritation, or a systemic adverse reaction develops, use.....decades of clinical use of another formulation of topical tretinoin. Although no definite.....ingestion of the drug may lead to the same adverse effects as those associated with..
http://www.fda.gov/cder/foi/label/1999/20922lbl.pdf (score=13)

þÿ
...and components are used for reproducible delivery of drug formulation,and these can be.....in the drug substance or drug product specification and is individually listed and limited.....formulation, container closure system, manufacturing,stability, controls of critical steps..
http://www.fda.gov/cder/guidance/4234fnl.pdf (score=13)

SLR46ap.whi.doc
...Therefore, inducers or inhibitors of CYP3A4 may affect estrogen drug metabolism. Inducers.....drug formulation. Distribution ..The distribution of exogenous estrogens is similar to that of.....If hypercalcemia occurs, use of the drug should be stopped and appropriate measures taken..
http://www.fda.gov/cder/foi/label/2004/010402S046lbl.pdf (score=13)

Container Closure Systems for Packaging Human Drugs and Biologics
...An ocular system usually consists of the drug formulation contained in a rate-controlling.....For most drug products, a drug product manufacturer may accept a packaging component lot based on receiving.....A composition change may occur as a result of a change in formulation or in a processing..
http://www.fda.gov/cder/guidance/1714fnl.htm (score=13)

8:00 a
...Drug Formulation and Development, and Tissue Engineering Issues.. Robert S. Langer, Sc.D.....Director, Office of Medical Policy, Center for Drug Evaluation & Research, FDA.. 3:40 p.m.....Drug Evaluation & Research, FDA.. 9:00 a.m. Obesity - Research.. David W.K. Acheson, M.D..
http://www.fda.gov/ohrms/dockets/ac/04/agenda/4039a1_updated%20agenda.htm (score=13)

Guidance for Industry - Content and Format of Chemistry, Manufacturing and...
...If an investigational drug formulation was different from that of the to-be-marketed finished.....This section should contain information on the final drug product including all drug substances and excipients in the.....A discussion of any differences in formulation, manufacturing process, or site between the..
http://www.fda.gov/cber/gdlns/cmcvacc.htm (score=13)

Photosafety Testing
...Information regarding the ultraviolet/visible radiation absorption spectrum for the drug substance or drug.....Although there are a number of differences, many of the proposed mechanisms by which drug substances or drug.....For example, a switch to a cream formulation from an acetone solution of a new..
http://www.fda.gov/cder/guidance/3281dft.htm (score=13)

Guidance- Content & Format CMC for Vaccine & Related Product
...If an investigational drug formulation was different from that of the to-be-marketed.....A list should be provided of all components in the drug product, including drug substance(s)and other ingredients.....A discussion of any differences in formulation, manufacturing process, or site between the..
http://www.fda.gov/cber/gdlns/cmcvacc.pdf (score=13)

þÿ
...formulation components or leaching from the container closure system, chemical impurities.....adequate acceptance criteria to ensure that batches of drug products meet each appropriate.....1 This guidance has been prepared by the Inhalation Drug Products LDPE Working Group of..
http://www.fda.gov/cder/guidance/4168dft.PDF (score=13)

May/June 1996 FDA Veterinarian Newsletter
...The types of studies needed to demonstrate the safety of the new animal drug include drug tolerance.....This will allow continued data collection for this drug formulation. In addition, CVM has.....A drug company or other sponsor pursuing approval of a new animal drug must first..
http://www.fda.gov/cvm/index/fdavet/1996/may96.htm (score=13)

Issued 02-17-1999 Guidance for Industry CMC & Establishment Description for...
...the availability of Revised Form FDA 356h "Application to Market a New Drug,Biologic, or.....If an investigational drug..formulation was different from that of the to-be-marketed finished.....A discussion of any differences in formulation, manufacturing process, or site between..
http://www.fda.gov/cber/gdlns/cmcplasma.pdf (score=13)

...Information regarding the ultraviolet/visible radiation absorption spectrum for the drug substance or drug.....Studies of dermal absorption of the drug substance for one formulation do not necessarily supply relevant data on.....Office of Training and Communication Division of Drug Information, HFD-240 Center for Drug Evaluation and Research Food and..
http://www.fda.gov/cder/guidance/3640fnl.doc (score=13)

Guidance for Industry - For the Submission of Chemistry, Manufacturing and...
...If an investigational drug formulation was different from that of the to-be-marketed finished.....A detailed description of the fractionation, formulation, and purification should be.....In the Federal Register of July 8, 1997, the Food and Drug Administration announced the..
http://www.fda.gov/cber/gdlns/cmcplasma.htm (score=13)

Las Vegas Injury Lawyer